Join us

A NEW BUSINESS DEVELOPMENT MANAGER FOR CONSUMER HEALTHCARE PRODUCTS DIVISION ONBOARD

Business people working on table and checking statistics chart data on sales development.

Ivan Banović is appointed Business Development Manager for Consumer Healthcare Products Division in Rhei Life.

NEW PRODUCTS ON THE BOSNIAN MARKET

Portrait of female doctor prescribing medication for patient.

Rhei Life is strengthening partnership with EL Pharma (Phoenix Group Member) and its presence in Bosnian market by signing agreement for 8 new Rhei Life products to be launched, marketed and promoted in Bosnia and Hercegovina.

#PharmaSynergy 2021

Close-up of wooden conference table with closed bottles of water, glasses, papers and pen, nobody in room

Rhei Life BD team successfully participated on #PharmaSynergy 2021 that took place on February 23-25 in Amsterdam, Netherlands.

NEW TEAMMATE IN REGULATORY TEAM APPOINTED

Iva Giba is appointed as Regulatory Affair Specialist, team in Rhei Life. She will be obtaining and maintaining MA approvals for medicinal products, medical devices and food suplements

RHEI LIFE AND DR. REDDY’S LABORATORIES SIGNED THE AGREEMENT FOR REPRESENTATION OF MEDICINES IN SERBIA AND BOSNIA AND HERZEGOVINA​

Petri dish with a blood sample in the hands of a scientist in the laboratory.

The new partnership with Dr. Reddy`s Laboratories will enrich Rhei Life hospital portfolio in Serbia and Bosnia and Herzegovina with several medicines.

HIV INFECTION THERAPY shortage in Bosnia

Efavirenz is used along with other medications to treat human immunodeficiency virus (HIV) infection. Even though this medicine was registered in Bosnia, a few years back shortages started, and the originator company withdrew it from the market. Our company imported it to fill the gap since it is still necessary in some therapeutical protocols. As a result of our partnership with a Portuguese pharma company we have stabilized the supply of this medicine to Bosnia and Herzegovina as a non-registered medicine.

VINBLASTINE – ONCOLOGY MEDICINE SHORTAGE ON THE POLISH MARKET

Synthesis of new vaccine or medicine against coronavirus. Clinical laboratory in process of chemical analysis. Collection of probe using automatic pipette

The shortage of Vinblastine medicine in Poland initiated our partnership with a state-owned wholesale company CEFARM. Our company supplied Vinblastine manufactured in Argentina to Cefarm in Poland in order to cover a local shortage of this important medicine used to treat various types of cancer.

FIRST IMPORTATION TO SERBIAN MARKET OF TRIENTINE, RARE DISEASE MEDICINE IN WILSON DISEASE FROM USA MARKET (TRIENTINE AMENAL PHARMACEUTICALS)

Lab.

FIRST IMPORTATION TO SERBIAN MARKET OF TRIENTINE, A RARE DISEASE MEDICINE FOR WILSON DISEASE FROM US MARKET (TRIENTINE AMENAL PHARMACEUTICALS)